Nama's AI scorecard currently rates Huntsman Sell (1.9 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

When does HUN report earnings?

Huntsman's next scheduled report is on Feb 16, 2027. Analysts expect EPS of $0.07.

What is the HUN price target?

The median analyst price target from 14 analysts is $10.50, with a range of $9.00 – $13.00.

Is HUN Shariah compliant?

Nama's AAOIFI-style screen reads Huntsman as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Does HUN pay a dividend?

Yes — Huntsman's dividend yield is 3.7%.

Nama Insights

Huntsman (HUN)

Basic Materials · Chemicals · NYSE

Huntsman (HUN) is a Basic Materials company in the Chemicals industry. It has a market capitalization of $1.66B and a free-cash-flow yield of 7.1%. Over the most recent reported fiscal year, revenue declined 5.8% and free cash flow per share grew 46.4%. Nama's AI scorecard rates it Sell, 1.9 out of 10. On 12-month momentum it ranks in the middle band of its market.

AI scorecard

Sell · 1.9/10

Clearly negative, short of the bottom band. As of Nov 7, 2026.

Momentum

Middle · +16.3% over 12 months ex. last

Middle fifth of its market on the past year's move.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-77.3%

How far the last close sits under the highest price of the past five years.

Market cap	$1.66B
Trailing P/E	—
Price / book	0.6
Price / sales	0.3
FCF yield	7.1%
Dividend yield	3.7%
Gross margin	12.9%
Operating margin	-0.7%
Net margin	-5.8%
Revenue growth (YoY)	-5.8%
Revenue growth (3-yr annual)	-10.9%
EPS growth (YoY)	—
FCF/share growth (YoY)	+46.4%
Beta	0.8
Exchange	NYSE
Sector	Basic Materials
Industry	Chemicals

HUN earnings

Next report: Feb 16, 2027 (Q4 2026, EPS estimate $0.07). Beat the EPS estimate in 2 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Nov 2, 2026	$0.04	$0.07	-42.9%	$1.72B
Q1 2026	Apr 30, 2026	-$0.20	-$0.21	+4.8%	$1.42B
Q4 2025	Feb 17, 2026	-$0.37	-$0.31	-19.4%	$1.35B
Q3 2025	Nov 6, 2025	-$0.03	-$0.15	+80.0%	$1.46B

HUN analyst price target

Median target $10.50 from 14 analysts, ranging $9.00 – $13.00.

Chemicals peers

Ticker	Company	Market cap	P/E
DOW	Dow	$22.73B	18.8
MEOH	Methanex	$5.13B	8.6
CE	Celanese	$5.10B	8.3
OLN	Olin	$1.97B	—
REX	REX American Resources	$1.31B	24.3

Explore live HUN data on Nama Insights →

Recent Congressional trades

Huntsman trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
David A Perdue , Jr	Senate	Sell	$15,001 - $50,000	—
David A Perdue , Jr	Senate	Buy	$1,001 - $15,000	—
David A Perdue , Jr	Senate	Buy	$1,001 - $15,000	—
Susan M Collins	Senate	Sell	$1,001 - $15,000	—

HUN FAQ

Is HUN a buy?: Nama's AI scorecard currently rates Huntsman Sell (1.9 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
When does HUN report earnings?: Huntsman's next scheduled report is on Feb 16, 2027. Analysts expect EPS of $0.07.
What is the HUN price target?: The median analyst price target from 14 analysts is $10.50, with a range of $9.00 – $13.00.
Is HUN Shariah compliant?: Nama's AAOIFI-style screen reads Huntsman as Not Shariah Compliant. At least one of the three ratios or the industry test failed.
Does HUN pay a dividend?: Yes — Huntsman's dividend yield is 3.7%.